These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30020736)

  • 21. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
    Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
    West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical capsaicin for cannabinoid hyperemesis syndrome.
    Cruz A; Paloucek FP; Petzel R
    Clin Toxicol (Phila); 2020 Sep; 58(9):938. PubMed ID: 31913735
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
    Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
    Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study.
    Pélissier F; Claudet I; Gandia-Mailly P; Benyamina A; Franchitto N
    J Emerg Med; 2016 Nov; 51(5):544-551. PubMed ID: 27485997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid Hyperemesis Syndrome: An Unexpected Problem in an Unusual Setting-A Case Report.
    Stuart R; Richards JR
    Mil Med; 2020 Sep; 185(9-10):e1894-e1896. PubMed ID: 32472123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid hyperemesis syndrome and topical capsaicin: treating smoke with fire?
    Wang JJ; Villeneuve E; Amiel JA; Gosselin S
    Clin Toxicol (Phila); 2018 Jan; 56(1):78. PubMed ID: 28681654
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cannabinoid hyperemesis syndrome should be considered by recurrent vomiting].
    Nordholm-Carstensen A
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid hyperemesis syndrome and topical capsaicin: treating smoke with fire? - the authors reply.
    Hafez Z; Mullins ME; Blohm E; O'Connor MJ; Dezieck L; Schwarz ES; Conicella A
    Clin Toxicol (Phila); 2018 Jan; 56(1):79. PubMed ID: 28730852
    [No Abstract]   [Full Text] [Related]  

  • 35. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid hyperemesis: marijuana puts patients in hot water.
    Wallace D; Martin AL; Park B
    Australas Psychiatry; 2007 Apr; 15(2):156-8. PubMed ID: 17464661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.